Bakteriofagterapi (Swedish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bakteriofagterapi" in Swedish language version.

refsWebsite
Global rank Swedish rank
2nd place
14th place
1st place
1st place
low place
869th place
1,180th place
11th place
low place
low place
4th place
17th place
low place
low place
low place
low place

caister.com

doi.org

dx.doi.org

  • Örmälä, Anni-Maria; Jalasvuori, Matti (2013). ”Phage therapy”. Bacteriophage 3 (1). doi:10.4161/bact.24219. 
  • Van Belleghem, Jonas D.; Dąbrowska, Krystyna; Vaneechoutte, Mario; Barr, Jeremy J.; Bollyky, Paul L. (2018). ”Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System”. Viruses 11(1): 10. doi:10.3390/v11010010. 
  • Kutter, Elizabeth; De Vos, Daniel; Gvasalia, Guram; Alavidze, Zemphira; Gogokhia, Lasha; Kuhl, Sarah (2010). ”Phage Therapy in Clinical Practice: Treatment of Human Infections”. Current Pharmaceutical Biotechnology 11 (1): sid. 69–86. doi:10.2174/138920110790725401. 
  • Lin, Derek M.; Koskella, Britt; Lin, Henry C. (2017). ”Phage therapy: An alternative to antibiotics in the age of multi-drug resistance”. World Journal of Gastrointestinal Pharmacology and Therapeutics 8 (3): sid. 162–173. doi:10.4292/wjgpt.v8.i3.162. 
  • Housby, John N.; Mann, Nicholas H. (2009). ”Phage Therapy”. Drug Discovery Today 14 (11-12): sid. 536-540. doi:10.1016/j.drudis.2009.03.006. 
  • Barr, Jeremy J. (2017). ”A bacteriophages journey through the human body”. Immunological Reviews 279 (1): sid. 106–122. doi:10.1111/imr.12565. 
  • Azam, Haeruman; Tanji, Yasunori (2019). ”Bacteriophage-host arm race: an update on the mechanism of phage resistance in bacteria and revenge of the phage with the perspective for phage therapy”. Applied Microbiology and Biotechnology 103 (5): sid. 2121–2131. doi:10.1007/s00253-019-09629-x. 
  • Poullain, Virginie; Gandon, Sylvain; Brockhurst, Michael A.; Buckling, Angus; Hochberg, Michael E. (2008). ”The Evolution of Specificity in Evolving and Coevolving Antagonistic Interactions Between a Bacteria and Its Phage”. Evolution 62 (1): sid. 1–11. doi:10.1111/j.1558-5646.2007.00260.x. 
  • Labrie, Simon J.; Samson, Julie E.; Moineau, Sylvain (2010). ”Bacteriophage resistance mechanisms”. Nature Reviews. Microbiology 8 (5): sid. 317–327. doi:10.1038/nrmicro2315. 
  • Bakhshinejad, Babak; Ghiasvand, Saeedeh (2017). ”Bacteriophages in the human gut: Our fellow travelers throughout life and potential biomarkers of heath or disease”. Virus Research 240: sid. 47–55. doi:10.1016/j.virusres.2017.07.013. 
  • Blum, Hubert E. (2017). ”The human microbiome”. Advances in Medical Sciences 62 (2): sid. 414–420. doi:10.1016/j.advms.2017.04.005. 
  • Hyman, Paul (2019). ”Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth”. Pharmaceuticals 12 (1). doi:10.3390/ph12010035. 
  • Cisek, Agata A.; Dąbrowska, Iwona; Gregorczyk, Karolina P.; Wyżewski, Zbigniew (2017). ”Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages”. Current Microbiology 74 (2): sid. 277–283. doi:10.1007/s00284-016-1166-x. 
  • Azeredo, Joana; Kluskens, Leon D.; Costa, Ana R.; Nobrega, Franklin L. (2015). ”Revisiting phage therapy: new applications for old resources”. Trends in Microbiology 23 (4): sid. 185–191. doi:10.1016/j.tim.2015.01.006. 
  • Loc-Carrillo, Catherine; Abedon, Stephen T. (2011). ”Pros and cons of phage therapy”. Bacteriophage 1 (2): sid. 111–114. doi:10.4161/bact.1.2.14590. 

eliava-institute.org

fls.fi

forskning.se

nih.gov

ncbi.nlm.nih.gov

  • Kropinski, Andrew M. (2006). ”Phage Therapy: Everything Old is New Again”. The Canadian Journal of Infectious Diseases & Medical Microbiology 17 (5): sid. 297–306. PMID 18382643. 

sverigesradio.se

web.archive.org